Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 10 885-889, Copyright © 1998 by American Association for Cancer Research

ARTICLES

Reliability of serum measurements of lignans and isoflavonoid phytoestrogens over a two-year period

A Zeleniuch-Jacquotte, H Adlercreutz, A Akhmedkhanov and P Toniolo
Nelson Institute of Environmental Medicine, Kaplan Comprehensive Cancer Center, New York University Medical Center, New York 10010-2598, USA.

We examined the distribution and long-term reliability of serum measurements of the two main human lignans, enterolactone and enterodiol, and the isoflavonoid phytoestrogens daidzein, genistein, equol, and O-Desmethylangolensin in the New York University Women's Health Study, a prospective cohort study of sex hormones and breast cancer. Serum samples collected at three yearly visits in 30 premenopausal and 30 postmenopausal women who had not been diagnosed with cancer or cardiovascular disease were included in the study. Assays were carried out by ion-exchange chromatography and capillary gas chromatography-mass spectrometry. Levels of isoflavonoid phytoestrogens were low, often at or below the sensitivity level of the assay. The reliability coefficients for these compounds were also low (< or =0.30). The median levels of enterodiol and enterolactone were 1.52 nmol/liter and 20.2 nmol/liter, respectively, and were comparable with the levels observed in omnivorous Finnish women living in the Helsinki area. A substantial number of women, though, had fairly high levels: for instance, 15% of the assays showed levels of enterolactone greater than the mean level observed in vegetarian Finnish women, i.e., 89.1 nmol/liter (H. Adlercreutz et al., Cancer Detec. Prev., 18: 259-271, 1994). The reliability coefficient of a single measurement of enterolactone was moderately high (0.55), suggesting that serum measurements of this compound could be a useful tool in prospective epidemiological studies with access to repeated blood or serum specimens. For instance, the reliability coefficient of the average of three measurements of enterolactone would be 0.79, a level considered acceptable in light of the other sources of error that are present in epidemiological studies (W. Willett, Stat. Med., 8: 1031-1040, 1989).

This article has been cited by other articles:

				I. E. J. Milder, A. Kuijsten, I. C. W. Arts, E. J. M. Feskens, E. Kampman, P. C. H. Hollman, and P. Van 't Veer Relation between Plasma Enterodiol and Enterolactone and Dietary Intake of Lignans in a Dutch Endoscopy-Based Population J. Nutr., May 1, 2007; 137(5): 1266 - 1271. [Abstract] [Full Text] [PDF]

				J. W. Erdman Jr., D. Balentine, L. Arab, G. Beecher, J. T. Dwyer, J. Folts, J. Harnly, P. Hollman, C. L. Keen, G. Mazza, et al. Flavonoids and Heart Health: Proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC J. Nutr., March 1, 2007; 137(3): 718S - 737S. [Abstract] [Full Text] [PDF]

				A. Kuijsten, I. C.W. Arts, P. C.H. Hollman, P. van't Veer, and E. Kampman Plasma enterolignans are associated with lower colorectal adenoma risk. Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1132 - 1136. [Abstract] [Full Text] [PDF]

				A. Kilkkinen, I. Erlund, M. J. Virtanen, G. Alfthan, K. Ariniemi, and J. Virtamo Serum Enterolactone Concentration and the Risk of Coronary Heart Disease in a Case-Cohort Study of Finnish Male Smokers Am. J. Epidemiol., April 15, 2006; 163(8): 687 - 693. [Abstract] [Full Text] [PDF]

				A. Kuijsten, I. C. W. Arts, P. van't Veer, and P. C. H. Hollman The Relative Bioavailability of Enterolignans in Humans Is Enhanced by Milling and Crushing of Flaxseed J. Nutr., December 1, 2005; 135(12): 2812 - 2816. [Abstract] [Full Text] [PDF]

				A. Stuedal, I. T. Gram, Y. Bremnes, H. Adlercreutz, M. B. Veierod, and G. Ursin Plasma Levels of Enterolactone and Percentage Mammographic Density among Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2154 - 2159. [Abstract] [Full Text] [PDF]

				D. Bhakta, I. dos Santos Silva, C. Higgins, L. Sevak, T. Kassam-Khamis, P. Mangtani, H. Adlercreutz, and A. McMichael A Semiquantitative Food Frequency Questionnaire Is a Valid Indicator of the Usual Intake of Phytoestrogens by South Asian Women in the UK Relative to Multiple 24-h Dietary Recalls and Multiple Plasma Samples J. Nutr., January 1, 2005; 135(1): 116 - 123. [Abstract] [Full Text] [PDF]

				A. Olsen, K. E. B. Knudsen, B. L. Thomsen, S. Loft, C. Stripp, K. Overvad, S. Moller, and A. Tjonneland Plasma Enterolactone and Breast Cancer Incidence by Estrogen Receptor Status Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2084 - 2089. [Abstract] [Full Text] [PDF]

				M. L. de Lemos and R. K. O'Brien Effects of flaxseed on breast cancer growth Journal of Oncology Pharmacy Practice, September 1, 2004; 10(3): 145 - 147. [Abstract] [PDF]

				A. H. Wu, M. C. Yu, C.-C. Tseng, N. C. Twaddle, and D. R. Doerge Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County Carcinogenesis, January 1, 2004; 25(1): 77 - 81. [Abstract] [Full Text] [PDF]

				A. Kilkkinen, J. Virtamo, M. J. Virtanen, H. Adlercreutz, D. Albanes, and P. Pietinen Serum Enterolactone Concentration Is Not Associated with Prostate Cancer Risk in a Nested Case-Control Study Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1209 - 1212. [Abstract] [Full Text]

				M. Vanharanta, S. Voutilainen, T. H. Rissanen, H. Adlercreutz, and J. T. Salonen Risk of Cardiovascular Disease-Related and All-Cause Death According to Serum Concentrations of Enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study Arch Intern Med, May 12, 2003; 163(9): 1099 - 1104. [Abstract] [Full Text] [PDF]

				J. W. Lampe Isoflavonoid and Lignan Phytoestrogens as Dietary Biomarkers J. Nutr., March 1, 2003; 133(3): 956S - 964. [Abstract] [Full Text] [PDF]

				K. Stumpf and H. Adlercreutz Short-Term Variations in Enterolactone in Serum, 24-Hour Urine, and Spot Urine and Relationship with Enterolactone Concentrations Clin. Chem., January 1, 2003; 49(1): 178 - 181. [Full Text] [PDF]

				L. K. Boker, Y. T. Van der Schouw, M. J. J. De Kleijn, P. F. Jacques, D. E. Grobbee, and P. H. M. Peeters Intake of Dietary Phytoestrogens by Dutch Women J. Nutr., June 1, 2002; 132(6): 1319 - 1328. [Abstract] [Full Text] [PDF]

				A. Kilkkinen, K. Stumpf, P. Pietinen, L. M Valsta, H. Tapanainen, and H. Adlercreutz Determinants of serum enterolactone concentration Am. J. Clinical Nutrition, June 1, 2001; 73(6): 1094 - 1100. [Abstract] [Full Text] [PDF]

				M. J. J. de Kleijn, Y. T. van der Schouw, P. W. F. Wilson, H. Adlercreutz, W. Mazur, D. E. Grobbee, and P. F. Jacques Intake of Dietary Phytoestrogens Is Low in Postmenopausal Women in the United States: The Framingham Study1-4 J. Nutr., June 1, 2001; 131(6): 1826 - 1832. [Abstract] [Full Text]

				P. Pietinen, K. Stumpf, S. Männistö, V. Kataja, M. Uusitupa, and H. Adlercreutz Serum Enterolactone and Risk of Breast Cancer: A Case-Control Study in Eastern Finland Cancer Epidemiol. Biomarkers Prev., April 1, 2001; 10(4): 339 - 344. [Abstract] [Full Text]